We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$116B
1-Year Est. Return
61.47%
This Fund
S&P 500
This Quarter
Est. Return
+35.47%
1 Year Est. Return
+61.47%
3 Year Est. Return
+172.42%
5 Year Est. Return
+231.94%
10 Year Est. Return
+892.64%
AUM
$116B
AUM Growth
+$19.5B
(+20%)
Cap. Flow
-$8.28B
Cap. Flow
% of AUM
-7.16%
Top 10 Holdings %
Top 10 Hldgs %
23.46%
Holding
2,577
New
241
Increased
1,367
Reduced
808
Closed
93
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOGM
Alphabet Inc Depositary Shares Series A Preferred Stock
GOOGM
|
+$752M |
| 2 |
UnitedHealth
UNH
|
+$672M |
| 3 |
GOOGN
Alphabet Inc Depositary Shares Series B Preferred Stock
GOOGN
|
+$631M |
| 4 |
Morgan Stanley
MS
|
+$567M |
| 5 |
Advanced Micro Devices
AMD
|
+$443M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$874M |
| 2 |
Microsoft
MSFT
|
+$674M |
| 3 |
NVIDIA
NVDA
|
+$469M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$432M |
| 5 |
Amphenol
APH
|
+$408M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.03% |
| 2 | Miscellaneous | 15.04% |
| 3 | Industrials | 10.75% |
| 4 | Healthcare | 8.02% |
| 5 | Financials | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
B&G Foods
BGS
$252M
| $67.1K | ﹤0.01% |
16,862
+2,846
| +20% | +$13.2K |
|
2352
Editas Medicine
EDIT
$396M
| $66.5K | ﹤0.01% |
20,536
+4,447
| +28% | +$13K |
|
2353
Cabaletta Bio
CABA
$351M
| $66.5K | ﹤0.01% |
+21,377
| New | +$70.3K |
|
2354
Lexeo Therapeutics
LXEO
$272M
| $66.2K | ﹤0.01% |
14,230
+3,525
| +33% | +$19.1K |
|
2355
Citizens
CIA
$182M
| $63.5K | ﹤0.01% |
+11,059
| New | +$60K |
|
2356
Rocket Pharmaceuticals
RCKT
$285M
| $63.5K | ﹤0.01% |
18,558
+3,908
| +27% | +$13K |
|
|
RC
2357
Ready Capital
RC
$220M
| $63K | ﹤0.01% |
36,005
+4,855
| +16% | +$8.53K |
|
2358
Eledon Pharmaceuticals
ELDN
$215M
| $62.7K | ﹤0.01% |
15,906
+2,690
| +20% | +$9.78K |
|
2359
Portillo's
PTLO
$253M
| $62.1K | ﹤0.01% |
+13,106
| New | +$63.5K |
|
2360
Akebia Therapeutics
AKBA
$248M
| $61.9K | ﹤0.01% |
54,334
+9,931
| +22% | +$11.8K |
|
2361
Verastem
VSTM
$701M
| $61.4K | ﹤0.01% |
16,083
+4,552
| +39% | +$22K |
|
2362
Playtika
PLTK
$812M
| $61.4K | ﹤0.01% |
+16,498
| New | +$57K |
|
2363
N-able
NABL
$756M
| $61.3K | ﹤0.01% |
16,709
+3,012
| +22% | +$12.5K |
|
2364
Bumble
BMBL
$351M
| $60.6K | ﹤0.01% |
18,940
+5,691
| +43% | +$19.5K |
|
|
OLPX
2365
DELISTED
Olaplex Holdings
OLPX
| $60K | ﹤0.01% |
29,264
+4,794
| +20% | +$9.77K |
|
2366
Comstock
LODE
$195M
| $59.9K | ﹤0.01% |
+14,406
| New | +$52.4K |
|
|
VOXR
2367
Vox Royalty Corp
VOXR
$378M
| $59.9K | ﹤0.01% |
+12,659
| New | +$69.7K |
|
2368
Granite Ridge Resources
GRNT
$586M
| $59.5K | ﹤0.01% |
13,492
+3,483
| +35% | +$18.3K |
|
2369
Compass Therapeutics
CMPX
$203M
| $59.3K | ﹤0.01% |
27,069
-348,251
| -93% | -$1.03M |
|
2370
Century Therapeutics
IPSC
$302M
| $59K | ﹤0.01% |
+24,067
| New | +$55K |
|
2371
Palisade Bio
PALI
$253M
| $58.8K | ﹤0.01% |
+28,143
| New | +$55.4K |
|
2372
Unisys
UIS
$169M
| $58.5K | ﹤0.01% |
15,975
+3,704
| +30% | +$11.6K |
|
2373
OmniAb
OABI
$670M
| $58.1K | ﹤0.01% |
23,613
+5,423
| +30% | +$10.8K |
|
2374
Nu Skin
NUS
$225M
| $58K | ﹤0.01% |
+10,990
| New | +$70.3K |
|
2375
Krispy Kreme
DNUT
$501M
| $58K | ﹤0.01% |
16,434
+3,010
| +22% | +$10.7K |
|
Similar funds
VOYA Investment Management's Q2 2026 Portfolio in Review
As of Q2 2026, VOYA Investment Management held 2,577 positions worth $116B, up 20% from $96.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
VOYA Investment Management withdrew a net $8.28B in Q2 2026, closing 93 positions and reducing 808 holdings. Its most notable exit was QXO Inc 5.50% Series B Preferred Stock, an estimated $151M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Miscellaneous and Industrials.
Against the trend, VOYA Investment Management opened a new position in Alphabet Inc Depositary Shares Series A Preferred Stock worth $762M.
- VOYA Investment Management's largest Q2 2026 buy was Alphabet Inc Depositary Shares Series A Preferred Stock: 14,968,500 shares worth $762M.
- VOYA Investment Management added most to UnitedHealth in Q2 2026, an estimated $672M increase.
- VOYA Investment Management's biggest Q2 2026 reduction was Apple, cutting an estimated $874M.
- VOYA Investment Management fully exited QXO Inc 5.50% Series B Preferred Stock in Q2 2026, selling an estimated $151M.
- VOYA Investment Management's ten largest holdings make up 23% of its $116B portfolio in Q2 2026.
- VOYA Investment Management opened 241 new positions and closed 93 in Q2 2026.
- VOYA Investment Management's portfolio value rose 20% quarter-over-quarter to $116B.
Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.